Manufacturers Life Insurance Company, The Biocryst Pharmaceuticals Inc Transaction History
Manufacturers Life Insurance Company, The
- $102 Billion
- Q2 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 212,581 shares of BCRX stock, worth $1.68 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
212,581
Previous 99,429
113.8%
Holding current value
$1.68 Million
Previous $505,000
160.0%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding BCRX
# of Institutions
257Shares Held
173MCall Options Held
397KPut Options Held
444K-
Black Rock Inc. New York, NY20MShares$158 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.8MShares$149 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.6MShares$99.6 Million1.06% of portfolio
-
State Street Corp Boston, MA9.35MShares$74 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.83MShares$69.9 Million4.25% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.47B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...